Drug Shortage Report for TARO-CAPECITABINE
| Report ID | 240428 |
| Drug Identification Number | 02457504 |
| Brand name | TARO-CAPECITABINE |
| Common or Proper name | Capecitabine |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CAPECITABINE |
| Strength(s) | 500MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 120 Bottles |
| ATC code | L01BC |
| ATC description | ANTIMETABOLITES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-10-10 |
| Estimated end date | 2024-10-25 |
| Actual end date | 2024-10-25 |
| Shortage status | Resolved |
| Updated date | 2024-11-11 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-11-11 | French | Compare |
| v3 | 2024-11-11 | English | Compare |
| v2 | 2024-10-16 | French | Compare |
| v1 | 2024-10-16 | English | Compare |
Showing 1 to 4 of 4